600511 国药股份
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)2.52311.19412.15714.31114.551
总资产报酬率 ROA (%)1.3025.5765.9376.9166.817
投入资产回报率 ROIC (%)2.0508.7139.45311.29411.487

边际利润分析
销售毛利率 (%)6.0996.5947.1068.0318.401
营业利润率 (%)4.4754.9975.2925.9255.923
息税前利润/营业总收入 (%)4.4554.9145.1105.6445.844
净利润/营业总收入 (%)3.6263.9824.2094.6974.679

收益指标分析
经营活动净收益/利润总额(%)88.86180.19482.66385.36584.828
价值变动净收益/利润总额(%)21.24321.80018.69012.61610.849
营业外收支净额/利润总额(%)0.031-0.828-0.897-0.460-0.262

偿债能力分析
流动比率 (X)2.1812.0772.0432.0352.022
速动比率 (X)1.8201.7401.7101.7501.731
资产负债率 (%)42.42944.64245.67445.97446.437
带息债务/全部投入资本 (%)12.80116.15819.17815.01216.498
股东权益/带息债务 (%)647.388492.994396.060531.600472.573
股东权益/负债合计 (%)124.085113.238107.364105.737103.384
利息保障倍数 (X)-209.950-117.852-38.006-22.238-92.200

营运能力分析
应收账款周转天数 (天)94.26286.04275.73753.26045.326
存货周转天数 (天)36.67837.27134.14930.24231.237